We are all witnesses to a period of astonishing progress in our understanding of the genetic basis of diabetes, and the advances of recent months are arguably the most important made since the role of the HLA region was recognised in type 1 diabetes. The number of genetic regions causally implicated is now 11 each for type 1 and type 2 diabetes [1‐9], and is set to rise further. The bewildering pace of new discovery stands in stark contrast to the slow progress that characterised the previous two decades, with a total combined output of three confirmed genes for type 2 diabetes and six for type 1 (Fig. 1). At last, it seems, our understanding of the genetic basis of complex, multifactorial forms of diabetes is catching up with that of rarer, single-gene disorders.
WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.